Methylphenidate leads to disruptions in rest/wake patterns after discontinuation
Carolyn Cueto1, Magdalena R Gonzales1, Alexandra N Tejada1
1Department of Psychology, California State University San Bernardino, San Bernardino, CA, 92407, USA.
Insights
Methylphenidate (MPH) treatment for ADHD may alter sleep patterns in adolescent and adult rats. Discontinuation of MPH can lead to lasting reductions in sleep quality, suggesting potential long-term effects on rest and circadian rhythms.
Area of Science:
- Neuroscience
- Pharmacology
- Sleep Medicine
Background:
- Children with ADHD often experience sleep problems.
- Methylphenidate (MPH) is a common ADHD treatment, raising concerns about its impact on sleep.
- Existing evidence on MPH's effects on pediatric sleep is inconsistent.
Purpose of the Study:
- To investigate the effects of MPH on 24-hour rest/wake activity and circadian rhythms.
- To compare these effects in adolescent versus adult rats.
Main Methods:
- Male and female Long-Evans rats received MPH (1 or 2 mg/kg) or control for 10 days during adolescence or adulthood.
- Non-invasive activity monitors assessed circadian rhythms and activity patterns over a 24-hour cycle.
- Activity was analyzed during MPH treatment, acute withdrawal, and after 10 days of prolonged withdrawal.
Main Results:
- MPH increased activity in a dose- and age-specific manner.
- Adult rats showed more active episodes during the dark period and fragmented activity during early withdrawal.
- MPH impaired rest quality in female rats, with disruptions persisting and worsening after prolonged withdrawal.
Conclusions:
- MPH enhances activity during treatment in an age- and sex-dependent way.
- MPH discontinuation may cause lasting reductions in sleep quality in both adolescent and adult rats.
- These findings highlight potential long-term sleep disturbances following psychostimulant exposure.
Abstract:
Children with attention-deficit/hyperactivity disorder (ADHD) experience more sleep problems than their peers. As stimulant medications, particularly methylphenidate (MPH), are the most common treatment for pediatric ADHD, there has been growing interest in whether such medications contribute to sleep disturbances and the development of sleep disorders later in life. Despite ongoing interest, evidence related to MPH on sleep functioning in children remains mixed. The present study investigated the effects of MPH on 24-hour rest/wake activity patterns and circadian rhythms in adolescent versus adult rats. Male and female Long-Evans rats were administered MPH (1 or 2 mg/kg, i.p.) or control twice daily for 10 days during either adolescence (PD 30-39) or adulthood (PD 80-89). Non-invasive activity monitors, secured to each rat using custom-fitted jackets, were used to assess circadian rhythms and detailed activity patterns over a 24-hour reverse light/dark cycle. Microanalysis of activity patterns were assessed on the last day of MPH treatment, during acute discontinuation, and after 10 days of prolonged discontinuation. Results showed that repeated MPH administration produced dose- and age-specific increases in activity across the light/dark cycle on the last day of treatment. In adults, this was associated with longer and more frequent active episodes during the dark period, and transient increases in fragmented activity during early withdrawal. MPH also impaired rest quality in female rats, reflected by fewer rest episodes and increased fragmentation during the light period. While some of these disruptions persisted immediately after discontinuation, more pronounced impairments in rest quality emerged after 10 days of withdrawal. These findings suggest that while MPH may enhance activity during treatment in an age- and sex-dependent manner, its discontinuation may lead to lasting reductions in sleep quality in both adolescents and adults who are transiently exposed to the psychostimulants.
Related Concept Videos
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Narcolepsy
Management of Insomnia
REM Sleep Behavior Disorder
RBD is significantly associated with...


